{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:43:37Z","timestamp":1774323817993,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670315"],"award-info":[{"award-number":["81670315"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7172059"],"award-info":[{"award-number":["7172059"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>High blood glucose impairs voltage-gated K<jats:sup>+<\/jats:sup> (Kv) channel-mediated vasodilation in rat coronary artery smooth muscle cells (CSMCs) via oxidative stress. Advanced glycation end product (AGE) and receptor for AGE (RAGE) axis has been found to impair coronary dilation by reducing Kv channel activity in diabetic rat small coronary arteries (RSCAs). However, its underlying mechanism remain unclear. Here, we used isolated arteries and primary CSMCs to investigate the effect of AGE incubation on Kv channel-mediated coronary dilation and the possible involvement of peroxisome proliferators-activated receptor (PPAR) -\u03b3 pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The RSCAs and primary CSMCs were isolated, cultured, and treated with bovine serum albumin (BSA), AGE-BSA, alagrebrium (ALA, AGE cross-linking breaker), pioglitazone (PIO, PPAR-\u03b3 activator) and\/or GW9662 (PPAR-\u03b3 inhibitor). The groups were accordingly divided as control, BSA, AGE, AGE\u2009+\u2009ALA, AGE\u2009+\u2009PIO, or AGE\u2009+\u2009PIO\u2009+\u2009GW9662. Kv channel-mediated dilation was analyzed using wire myograph. Histology and immunohistochemistry of RSCAs were performed. Western blot was used to detect the protein expression of RAGE, major Kv channel subunits expressed in CSMCs (Kv1.2 and Kv1.5), PPAR-\u03b3, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-2 (NOX-2).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>AGE markedly reduced Forskolin-induced Kv channel-mediated dilation of RSCAs by engaging with RAGE, and ALA or PIO significantly reversed the functional loss of Kv channel. In both RSCAs and CSMCs, AGE reduced Kv1.2\/1.5 expression, increased RAGE and NOX-2 expression, and inhibited PPAR-\u03b3 expression, while ALA or PIO treatment partially reversed the inhibiting effects of AGE on Kv1.2\/1.5 expression, accompanied by the downregulation of RAGE and decreased oxidative stress. Meanwhile, silencing of RAGE with siRNA remarkably alleviated the AGE-induced downregulation of Kv1.2\/1.5 expression in CSMCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>AGE reduces the Kv channel expression in CSMCs and further impairs the Kv channel-mediated dilation in RSCAs. The AGE\/RAGE axis may enhance oxidative stress by inhibiting the downstream PPAR-\u03b3 pathway, thus playing a critical role in the dysfunction of Kv channels.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-020-01613-y","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T14:06:56Z","timestamp":1594735616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of peroxisome proliferators-activated receptor-gamma in advanced glycation end product-mediated functional loss of voltage-gated potassium channel in rat coronary arteries"],"prefix":"10.1186","volume":"20","author":[{"given":"Side","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huirong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5534-5925","authenticated-orcid":false,"given":"Weiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"issue":"4","key":"1613_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","volume":"4","author":"Z Hegab","year":"2012","unstructured":"Hegab Z, Gibbons S, Neyses L, Mamas MA. Role of advanced glycation end products in cardiovascular disease. World J Cardiol. 2012;4(4):90\u2013102.","journal-title":"World J Cardiol"},{"issue":"2","key":"1613_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.molmet.2013.11.006","volume":"3","author":"A Stirban","year":"2013","unstructured":"Stirban A, Gawlowski T, Roden M. Vascular effects of advanced glycation end products: clinical effects and molecular mechanisms. Mol Metab. 2013;3(2):94\u2013108.","journal-title":"Mol Metab"},{"issue":"8","key":"1613_CR3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1161\/CIR.0000000000000230","volume":"132","author":"CS Fox","year":"2015","unstructured":"Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, et al. Update on Prevention of Cardiovascular Disease in Adults with Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement from the American Heart Association and the American Diabetes Association. Circulation. 2015;132(8):691\u2013718.","journal-title":"Circulation"},{"issue":"1","key":"1613_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1258\/ebm.2009.009201","volume":"235","author":"GM Dick","year":"2010","unstructured":"Dick GM, Tune JD. Role of potassium channels in coronary vasodilation. Exp Biol Med. 2010;235(1):10\u201322.","journal-title":"Exp Biol Med"},{"issue":"1","key":"1613_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1537-1891(02)00125-8","volume":"38","author":"Y Liu","year":"2002","unstructured":"Liu Y, Gutterman DD. The coronary circulation in diabetes: influence of reactive oxygen species on K+ channel-mediated vasodilation. Vascul Pharmacol. 2002;38(1):43\u20139.","journal-title":"Vascul Pharmacol"},{"issue":"7","key":"1613_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/CIRCRESAHA.111.263525","volume":"111","author":"LK Svoboda","year":"2012","unstructured":"Svoboda LK, Reddie KG, Zhang L, Vesely ED, Williams ES, Schumacher SM, et al. Redox-sensitive sulfenic acid modification regulates surface expression of the cardiovascular voltage-gated potassium channel Kv1.5. Circ Res. 2012;111(7):842\u201353.","journal-title":"Circ Res"},{"issue":"7","key":"1613_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1161\/CIRCRESAHA.115.306642","volume":"117","author":"V Ohanyan","year":"2015","unstructured":"Ohanyan V, Yin L, Bardakjian R, Kolz C, Enrick M, Hakobyan T, et al. Requisite role of Kv1.5 channels in coronary metabolic dilation. Circ Res. 2015;117(7):612\u201321.","journal-title":"Circ Res"},{"issue":"2","key":"1613_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1161\/hh1401.093294","volume":"89","author":"Y Liu","year":"2001","unstructured":"Liu Y, Terata K, Rusch NJ, Gutterman DD. High glucose impairs voltage-gated K(+) channel current in rat small coronary arteries. Circ Res. 2001;89(2):146\u201352.","journal-title":"Circ Res"},{"issue":"3","key":"1613_CR9","doi-asserted-by":"publisher","first-page":"H1213","DOI":"10.1152\/ajpheart.00226.2003","volume":"285","author":"H Li","year":"2003","unstructured":"Li H, Chai Q, Gutterman DD, Liu Y. Elevated glucose impairs cAMP-mediated dilation by reducing Kv channel activity in rat small coronary smooth muscle cells. Am J Physiol Heart Circ Physiol. 2003;285(3):H1213\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"1613_CR10","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.2337\/diabetes.53.9.2436","volume":"53","author":"H Li","year":"2004","unstructured":"Li H, Gutterman DD, Rusch NJ, Bubolz A, Liu Y. Nitration and functional loss of voltage-gated K+ channels in rat coronary microvessels exposed to high glucose. Diabetes. 2004;53(9):2436\u201342.","journal-title":"Diabetes"},{"issue":"5","key":"1613_CR11","doi-asserted-by":"publisher","first-page":"H1873","DOI":"10.1152\/ajpheart.00357.2005","volume":"289","author":"AH Bubolz","year":"2005","unstructured":"Bubolz AH, Li H, Wu Q, Liu Y. Enhanced oxidative stress impairs cAMP-mediated dilation by reducing Kv channel function in small coronary arteries of diabetic rats. Am J Physiol Heart Circ Physiol. 2005;289(5):H1873\u201380.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"1613_CR12","doi-asserted-by":"publisher","first-page":"H2231","DOI":"10.1152\/ajpheart.00717.2007","volume":"293","author":"AH Bubolz","year":"2007","unstructured":"Bubolz AH, Wu Q, Larsen BT, Gutterman DD, Liu Y. Ebselen reduces nitration and restores voltage-gated potassium channel function in small coronary arteries of diabetic rats. Am J Physiol Heart Circ Physiol. 2007;293(4):H2231\u20137.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"1613_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142865","volume":"10","author":"W Su","year":"2015","unstructured":"Su W, Li W, Chen H, Liu H, Huang H, Li H. Advanced Glycation end products impair voltage-gated K+ channels-mediated coronary vasodilation in diabetic rats. PLoS One. 2015;10(11):e0142865.","journal-title":"PLoS One"},{"issue":"6","key":"1613_CR14","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.2337\/db11-0750","volume":"61","author":"ML Freidja","year":"2012","unstructured":"Freidja ML, Tarhouni K, Toutain B, Fassot C, Loufrani L, Henrion D. The AGE-breaker ALT-711 restores high blood flow\u2013dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes. Diabetes. 2012;61(6):1562\u201372.","journal-title":"Diabetes"},{"key":"1613_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1475-2840-13-55","volume":"13","author":"ML Freidja","year":"2014","unstructured":"Freidja ML, Vessi\u00e8res E, Toutain B, Guihot AL, Custaud MA, Loufrani L, et al. AGEs breaking and antioxidant treatment improves endothelium-dependent dilation without effect on flow-mediated remodeling of resistance arteries in old Zucker diabetic rats. Cardiovasc Diabetol. 2014;13:55.","journal-title":"Cardiovasc Diabetol"},{"key":"1613_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/CIRCRESAHA.116.309491","volume":"120","author":"Y Nishijima","year":"2017","unstructured":"Nishijima Y, Cao S, Chabowski DS, Korishettar A, Ge A, Zheng X, et al. Contribution of Kv1.5 Channel to Hydrogen Peroxide\u2013Induced Human Arteriolar Dilation and Its Modulation by Coronary Artery Disease. Circ Res. 2017;120:658\u201369.","journal-title":"Circ Res"},{"issue":"3","key":"1613_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.phrs.2009.01.006","volume":"60","author":"S Yamagishi","year":"2009","unstructured":"Yamagishi S, Nakamura K, Matsui T. Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease. Pharmacol Res. 2009;60(3):174\u20138.","journal-title":"Pharmacol Res"},{"issue":"4","key":"1613_CR18","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.3892\/mmr.2014.3113","volume":"11","author":"BB Di","year":"2015","unstructured":"Di BB, Li HW, Li WP, Shen XH, Sun ZJ, Wu X. Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells. Mol Med Rep. 2015;11(4):2601\u20137.","journal-title":"Mol Med Rep"},{"issue":"2","key":"1613_CR19","doi-asserted-by":"publisher","first-page":"H491","DOI":"10.1152\/ajpheart.00464.2008","volume":"295","author":"X Gao","year":"2008","unstructured":"Gao X, Zhang H, Schmidt AM, Zhang C. AGE\/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol Heart Circ Physiol. 2008;295(2):H491\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"1613_CR20","doi-asserted-by":"publisher","first-page":"H475","DOI":"10.1152\/ajpheart.00644.2008","volume":"295","author":"A Csiszar","year":"2008","unstructured":"Csiszar A, Ungvari Z. Endothelial dysfunction and vascular inflammation in type 2\u2002diabetes: interaction of AGE\/RAGE and TNF-alpha signaling. Am J Physiol Heart Circ Physiol. 2008;295(2):H475\u20136.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"1613_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.metabol.2015.11.007","volume":"65","author":"M Chen","year":"2016","unstructured":"Chen M, Li H, Wang G, Shen X, Zhao S, Su W. Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-\u03b3). Metabolism. 2016;65(4):441\u201353.","journal-title":"Metabolism"},{"key":"1613_CR22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1440-1681.1992.tb00420.x","volume":"19","author":"GA McPherson","year":"1992","unstructured":"McPherson GA. Assessing vascular reactivity of arteries in the small vessel myograph. Clin Exp Pharmacol Physiol. 1992;19:815\u201325.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1613_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ijcard.2016.08.243","volume":"223","author":"A Dhar","year":"2016","unstructured":"Dhar A, Udumula MP, Medapi B, Bhat A, Dhar I, Malapati P, et al. Pharmacological evaluation of novel alagebrium analogs as methylglyoxal scavengers in vitro in cardiac myocytes and in vivo in SD rats. Int J Cardiol. 2016;223:581\u20139.","journal-title":"Int J Cardiol"},{"issue":"11","key":"1613_CR24","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1161\/hh2301.100817","volume":"89","author":"KS Thorneloe","year":"2001","unstructured":"Thorneloe KS, Chen TT, Kerr PM, Grier EF, Horowitz B, Cole WC. Molecular composition of 4-aminopyridine-sensitive voltage-gated K(+) channels of vascular smooth muscle. Circ Res. 2001;89(11):1030\u20137.","journal-title":"Circ Res"},{"issue":"2","key":"1613_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00424-013-1324-y","volume":"466","author":"LM Zhao","year":"2014","unstructured":"Zhao LM, Wang Y, Ma XZ, Wang NP, Deng XL. Advanced glycation end products impair K (Ca)3.1- and K(Ca)2.3-mediated vasodilatation via oxidative stress in rat mesenteric arteries. Pflugers Arch. 2014;466(2):307\u201317.","journal-title":"Pflugers Arch"},{"key":"1613_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","volume":"2","author":"C Ott","year":"2014","unstructured":"Ott C, Jacobs K, Haucke E, Navarrete Santos A, Grune T, Simm A. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014;2:411\u201329.","journal-title":"Redox Biol"},{"issue":"4","key":"1613_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1046\/j.1440-1681.2002.03649.x","volume":"29","author":"Y Liu","year":"2002","unstructured":"Liu Y, Gutterman DD. Oxidative stress and potassium channel function. Clin Exp Pharmacol Physiol. 2002;29(4):305\u201311.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"7","key":"1613_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1161\/CIRCRESAHA.115.307281","volume":"117","author":"D Chabowski","year":"2015","unstructured":"Chabowski D, Gutterman D. Unveiling the mechanism of coronary metabolic vasodilation: voltage-gated potassium channels and hydrogen peroxide. Circ Res. 2015;117(7):589\u201391.","journal-title":"Circ Res"},{"issue":"1","key":"1613_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/cvr\/cvp031","volume":"82","author":"L Gao","year":"2009","unstructured":"Gao L, Mann GE. Vascular NAD(P)H oxidase activation in\u2002diabetes: a double-edged sword in redox signalling. Cardiovasc Res. 2009;82(1):9\u201320.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1613_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066611","volume":"8","author":"YJ Chen","year":"2013","unstructured":"Chen YJ, Sheu ML, Tsai KS, Yang RS, Liu SH. Advanced glycation end products induce peroxisome proliferator-activated receptor \u03b3 down-regulation-related inflammatory signals in human chondrocytes via toll-like receptor-4 and receptor for advanced glycation end products. PLoS One. 2013;8(6):e66611.","journal-title":"PLoS One"},{"issue":"5","key":"1613_CR31","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1248\/bpb.34.618","volume":"34","author":"X Yuan","year":"2011","unstructured":"Yuan X, Zhang Z, Gong K, Zhao P, Qin J, Liu N. Inhibition of reactive oxygen species\/extracellular signal-regulated kinases pathway by pioglitazone attenuates advanced glycation end products-induced proliferation of vascular smooth muscle cells in rats. Biol Pharm Bull. 2011;34(5):618\u201323.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"1613_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1124\/jpet.105.095125","volume":"317","author":"K Wang","year":"2006","unstructured":"Wang K, Zhou Z, Zhang M, Fan L, Forudi F, Zhou X, et al. Peroxisome proliferator activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. J Pharmacol Exp Ther. 2006;317(1):37\u201343.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01613-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01613-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01613-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T23:28:07Z","timestamp":1626218887000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01613-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1613"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01613-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"11 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Animal Care and Use Committee of Beijing Friendship Hospital, Capital Medical University (Beijing, China).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"337"}}